ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Haoma Medica Completes First-in-Human Trial for Osteoporosis Treatment
December 14, 2020Haoma Medica announced the completion of a first-in-human trial for NaQuinate, a naphthoquinone carboxylic acid, which is being developed as a novel orally administered therapeutic for osteoporosis. -
Haoma Medica Completes First-in-Human Trial for NaQuinate, a Novel Treatment in Development for Osteoporosis
November 27, 2020Haoma Medica announced today the completion of a first-in-human trial for NaQuinate, a naphthoquinone carboxylic acid, which is being developed as a novel orally administered therapeutic for osteoporosis.
Pharma Sources Insight January 2025
